Michael S. Hadley

1.8k citations

55 papers · 1.0k indexed · h-index 16

Organic Chemistry top 5%
Molecular Biology
Cellular and Molecular Neuroscience top 5%
Cognitive Neuroscience top 10%
Endocrine and Autonomic Systems top 5%

Co-authors: Graham J. Riley Geoffrey Stemp Michael Clark Barry S. Orlek John Evans Frank D. King Frank Brown Paul Wyman
Topics: Receptor Mechanisms and Signaling (13 papers)Pharmacological Receptor Mechanisms and Effects (7 papers)Asymmetric Synthesis and Catalysis (7 papers)
Cited by: Organic Chemistry Endocrine and Autonomic Systems Cellular and Molecular Neuroscience
Journals: Journal of Medicinal Chemistry Psychopharmacology Tetrahedron Letters
Partner nations: United Kingdom United States

In The Last Decade

Michael S. Hadley

52 papers receiving 949 citations

Peers

Countries citing papers authored by Michael S. Hadley

Since Specialization

Citations

This map shows the geographic impact of Michael S. Hadley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Hadley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Hadley more than expected).

Fields of papers citing papers by Michael S. Hadley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael S. Hadley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Hadley. The network helps show where Michael S. Hadley may publish in the future.

Co-authorship network of co-authors of Michael S. Hadley

This figure shows the co-authorship network connecting the top 25 collaborators of Michael S. Hadley. A scholar is included among the top collaborators of Michael S. Hadley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael S. Hadley. Michael S. Hadley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cardiac Magnetic Resonance for Structural Aortic Valve Stenosis Procedures 2024 ·Journal of Clinical Medicine ·(unknown),Michael S. Hadley,Javier Sanz	1
2	PO-06-197 VENTRICULAR TACHYCARDIA ABLATION IN A PATIENT WITH LEFT VENTRICULAR PSEUDOANEURYSM USING PULSED FIELD ABLATION 2024 ·Heart Rhythm ·(unknown),Daniel R. Musikantow,Michael S. Hadley,Kelly Jia,Iwanari Kawamura,Mohit K. Turagam,Srinivas R. Dukkipati,Vivek Y. Reddy	0
3	‘Is it the same patient?’ Evidence of significant cardiac amyloid regression 2023 ·European Heart Journal - Cardiovascular Imaging ·Solomon Bienstock,(unknown),Michael S. Hadley,Javier Sanz,Gina LaRocca	0
4	Heterologous high-level E. coli expression, purification and biophysical characterization of the spine-associated RapGAP (SPAR) PDZ domain 2008 ·Protein Expression and Purification ·Breann L. Brown,Michael S. Hadley,Rebecca Page	8
5	Identification of a potent and selective 5-HT1B receptor antagonist 2005 ·Bioorganic & Medicinal Chemistry Letters ·Paul Wyman,(unknown),(unknown),(unknown),Mervyn Thompson,Paul W. Smith,Michael S. Hadley,Gary Price,Claire M. Scott,Lee A. Dawson	2
6	The design of 8,8-Dimethyl[1,6]naphthyridines as potential anticonvulsant agents 2003 ·Bioorganic & Medicinal Chemistry Letters ·Nigel Austin,Michael S. Hadley,John D. Harling,Frank P. Harrington,Gregor J. Macdonald,Darren J. Mitchell,Graham J. Riley,Tania O. Stean,Geoffrey Stemp,Sharon C. Stratton,Mervyn Thompson,Neil Upton	22
7	1,3-Biarylureas as selective non-peptide antagonists of the orexin-1 receptor 2001 ·Bioorganic & Medicinal Chemistry Letters ·Roderick A. Porter,Wai N. Chan,Steven Coulton,Amanda Johns,Michael S. Hadley,Katherine L. Widdowson,Jeffrey C. Jerman,Stephen Brough,Martyn C. Coldwell,Darren Smart,Frances Jewitt,Philip D. Jeffrey,Nigel Austin	119
8	Design and synthesis of novel 2,3-dihydro-1H-isoindoles with high affinity and selectivity for the dopamine D3 receptor 2001 ·Bioorganic & Medicinal Chemistry Letters ·Nigel Austin,Kim Y. Avenell,Izzy Boyfield,Clive L. Branch,Michael S. Hadley,Philip D. Jeffrey,Christopher N. Johnson,Gregor J. Macdonald,(unknown),Graham J. Riley,Alexander B. Smith,Geoffrey Stemp,Kevin M. Thewlis,Antonio Vong,Martyn Wood	13
9	Novel 2,3,4,5-tetrahydro-1H-3-benzazepines with high affinity and selectivity for the dopamine D3 receptor 2000 ·Bioorganic & Medicinal Chemistry Letters ·Nigel Austin,Kim Y. Avenell,Izzy Boyfield,Clive L. Branch,Michael S. Hadley,Philip D. Jeffrey,Christopher N. Johnson,Gregor J. Macdonald,David J. Nash,Graham J. Riley,Alexander B. Smith,Geoffrey Stemp,Kevin M. Thewlis,Antonio Vong,Martyn Wood	15
10	Evaluation of a Series of Anticonvulsant 1,2,3,4-Tetrahydroisoquinolinyl-benzamides 2000 ·Bioorganic & Medicinal Chemistry ·Wai N. Chan,Michael S. Hadley,John D. Harling,Hugh J. Herdon,Barry S. Orlek,Graham J. Riley,(unknown),Tania O. Stean,Mervyn Thompson,Neil Upton,Robert W. Ward	8
11	Heterocyclic analogues of 2-aminotetralins with high affinity and selectivity for the dopamine D3 receptor 1999 ·Bioorganic & Medicinal Chemistry Letters ·Kim Y. Avenell,Izzy Boyfield,Michael S. Hadley,Christopher N. Johnson,David J. Nash,Graham J. Riley,Geoffrey Stemp	14
12	Identification of (−)-cis-6-acetyl-4S-(3-chloro-4-fluoro-benzoylamino)-3,4-dihydro-2,2-dimethyl-2H-benzo[b]pyran-3S-ol as a potential antimigraine agent 1999 ·Bioorganic & Medicinal Chemistry Letters ·Wai N. Chan,John Evans,Michael S. Hadley,Hugh J. Herdon,Jeffrey C. Jerman,Andrew A. Parsons,Simon Read,Tania O. Stean,Mervyn Thompson,Neil Upton	46
13	Fused aminotetralins: novel antagonists with high selectivity for the dopamine D3 receptor 1998 ·Bioorganic & Medicinal Chemistry Letters ·Kim Y. Avenell,Izzy Boyfield,Martyn C. Coldwell,Michael S. Hadley,(unknown),(unknown),Christopher N. Johnson,(unknown),Graham J. Riley,(unknown),Stephen A. Smith,(unknown),Geoffrey Stemp,Kevin M. Thewlis	6
14	Identification of a series of 1,2,3,4-tetrahydroisoquinolinyl- benzamides with potential anticonvulsant activity 1998 ·Bioorganic & Medicinal Chemistry Letters ·Wai N. Chan,Michael S. Hadley,John D. Harling,Hugh J. Herdon,Jeffrey C. Jerman,Barry S. Orlek,Tania O. Stean,Mervyn Thompson,Neil Upton,Robert W. Ward	12
15	Synthesis of Novel trans-4-(Substituted-benzamido)-3,4-dihydro-2H-benzo[b]pyran-3-ol Derivatives as Potential Anticonvulsant Agents with a Distinctive Binding Profile 1996 ·Journal of Medicinal Chemistry ·Wai N. Chan,John Evans,Michael S. Hadley,Hugh J. Herdon,Jeffrey C. Jerman,(unknown),Tania O. Stean,Mervyn Thompson,Neil Upton,Antonio Vong	22
16	Synthesis and antihypertensive activity of 3-[(substituted-carbonyl)amino]-2H-1-benzopyrans 1992 ·Journal of Medicinal Chemistry ·Frederick Cassidy,John Evans,Michael S. Hadley,(unknown),(unknown),Geoffrey Stemp	61
17	Substituted benzamides with conformationally restricted side chains. 4. Hetero-azabicyclo[x.y.0] derivatives as gastric prokinetic agents. 1992 ·Bioorganic & Medicinal Chemistry Letters ·Michael S. Hadley,Frank D. King,(unknown),David H. Turner	8
18	Comparison of azabicyclic esters and oxadiazoles as ligands for the muscarinic receptor 1991 ·Journal of Medicinal Chemistry ·Barry S. Orlek,Frank E. Blaney,Frank Brown,Michael Clark,Michael S. Hadley,(unknown),Graham J. Riley,(unknown),Harry J. Wadsworth,Paul Wyman	171
19	The selective dopamine antagonist properties of BRL 34778: a novel substituted benzamide 1988 ·Psychopharmacology ·Frank Brown,William Campbell,Michael Clark,(unknown),Michael S. Hadley,(unknown),Philip B. Mitchell,(unknown),Graham J. Riley,James Semple	5
20	Substituted benzamides with conformationally restricted side chains. 2. Indolizidine derivatives as central dopamine receptor antagonists 1988 ·Journal of Medicinal Chemistry ·Frank D. King,Michael S. Hadley,(unknown)	10

About Michael S. Hadley

Michael S. Hadley is a scholar working on Organic Chemistry, Physiology and Cellular and Molecular Neuroscience, having authored 55 papers that have together received 1.0k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (13 papers), Pharmacological Receptor Mechanisms and Effects (7 papers) and Asymmetric Synthesis and Catalysis (7 papers). The work is most often cited by research in Organic Chemistry (494 citations), Endocrine and Autonomic Systems (112 citations) and Cellular and Molecular Neuroscience (277 citations). Michael S. Hadley has collaborated with scholars based in United Kingdom and United States. Frequent co-authors include Graham J. Riley, Geoffrey Stemp, Michael Clark, Barry S. Orlek, John Evans, Frank D. King, Frank Brown, Paul Wyman, Nigel Austin and Wai N. Chan. Their work appears in journals such as Journal of Medicinal Chemistry, Psychopharmacology and Tetrahedron Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact